Neuronal IL-1R1 Signaling in Mild Closed Head Injury
轻度闭合性头部损伤中的神经元 IL-1R1 信号转导
基本信息
- 批准号:10518172
- 负责人:
- 金额:$ 44.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAgeAnimal Disease ModelsAnti-Inflammatory AgentsAttentionAutoimmune DiseasesAxonBehaviorBehavioral AssayBrainCellsChronicClosed head injuriesComplexDataDevelopmentElectrophysiology (science)ExhibitsFDA approvedFormulationFunctional disorderGene Expression ProfileGenesGoalsInflammationInflammatoryInflammatory ResponseInjuryInterleukin SuppressionInterleukin-1Interleukin-1 ReceptorsInterventionKnockout MiceKnowledgeLoxP-flanked alleleMaintenanceMediatingMemoryModelingMusNatureNerve DegenerationNervous System TraumaNeurodegenerative DisordersNeurogliaNeuronsPathway interactionsPeripheralPhasePhenotypePhysiologyProcessReceptor SignalingRecoveryRiboTagRoleSignal TransductionSynapsesSynaptic plasticitySystemTestingTherapeuticTissuesTraumatic Brain Injurycell typecognitive functioncognitive recoverycytokineexperimental studygenetic approachinflammatory milieuinterleukin-1 receptor accessory proteinknock-downmouse modelnerve injurynervous system disorderneuroinflammationneuroregulationnovelpreservationresponsesynaptic function
项目摘要
ABSTRACT
The cytokine interleukin-1 (IL-1) is well known to mediate detrimental inflammatory processes in peripheral
tissues. IL-1 is elevated in age and in neurodegenerative disease. As a result, IL-1 has become a major focus
of anti-inflammatory strategies to treat neuroinflammation following acute injury and in chronic
neurodegenerative disease. Surprisingly, there is scant evidence that neurons are damaged through the direct
actions of IL-1. To the contrary, a neuron-specific “non-canonical” IL-1 receptor (IL-1R1) pathway that
promotes, rather than erodes, neuronal viability has been identified. Despite this paradigm-shifting observation,
the non-canonical pathway has received little attention. Much remains unknown about how neuronal IL-1R1
signaling contributes to the brain's inflammatory milieu, synaptic physiology, and cognitive function, and
recover from injury and progression of neurodegeneration. This knowledge gap could undermine potential
neuroprotective approaches that target suppression of IL-1 as part of the mechanism-of-action.
To address this knowledge gap, we will use novel mouse models exhibiting neuron-specific modulation of IL-1
signaling (i.e., IL-1R1-floxed mice to look at neuron-specific knockdown and IL-1R1-restore mice to look at the
neuron-specific expression of IL-1R1). Our overarching hypothesis is that neuronal IL-1R1 signaling is
inherently protective.
We will test this hypothesis in the following Specific Aims:
SA1 Define the role of the neuronal IL-1R1 pathway in the inflammatory response to a CHI in mice.
SA2 Define the neuronal IL-1R1 pathway in homeostatic synaptic plasticity after a CHI in mice.
SA3 Determine the temporal role of neuronal IL-1R1 in the cognitive recovery following a CHI.
If our hypothesis is affirmed, we will provide knowledge of a new neuroprotective approach and enable the
development of new formulations of existing anti-inflammatory interventions that preserve the neuroprotective
functions of IL-1. The development of novel IL-1R1 therapies would include agents that only suppress the
inflammatory IL-1R1 pathway or only activate the neuroprotective IL-1R1 pathway.
摘要
众所周知,细胞因子白介素1(IL-1)在外周组织中介导有害的炎症过程
纸巾。IL-1在年龄和神经退行性疾病中升高。因此,IL-1成为人们关注的主要焦点
抗炎策略治疗急性和慢性损伤后的神经炎症
神经退行性疾病。令人惊讶的是,几乎没有证据表明神经元通过直接的
IL-1的作用。相反,神经元特异性的非规范的IL-1受体(IL-1R1)途径
促进而不是侵蚀神经元的活性已经被确定。尽管有这种范式转换的观察,
非正则途径几乎没有受到关注。关于神经元IL-1R1如何
信号有助于大脑的炎症环境、突触生理和认知功能,以及
从损伤中恢复和神经退变的进展。这种知识鸿沟可能会削弱潜力。
以抑制IL-1为目标的神经保护方法是作用机制的一部分。
为了解决这一知识鸿沟,我们将使用显示神经元特异性调节IL-1的新型小鼠模型
信号(即,IL-1R1诱导的小鼠查看神经元特异性基因敲除,而IL-1R1恢复的小鼠查看
神经元特异性表达IL-1R1)。我们的主要假设是神经元IL-1R1信号是
与生俱来的保护性。
我们将在以下具体目标中检验这一假设:
SA1定义了神经元IL-1R1通路在小鼠对CHI的炎症反应中的作用。
SA2在小鼠CHI后的稳态突触可塑性中定义了神经元IL-1R1通路。
SA3决定了神经元IL-1R1在脑缺血后认知恢复中的时间作用。
如果我们的假设得到证实,我们将提供一种新的神经保护方法的知识,并使
开发现有抗炎干预措施的新配方,以保护神经保护
IL-1的功能。新的IL-1R1疗法的开发将包括仅抑制
炎症性IL-1R1途径或仅激活神经保护性IL-1R1途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ADAM D BACHSTETTER其他文献
ADAM D BACHSTETTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ADAM D BACHSTETTER', 18)}}的其他基金
Drug repurposing for Alzheimer’s disease-related inflammation caused by a TBI
药物再利用,治疗 TBI 引起的阿尔茨海默病相关炎症
- 批准号:
10590132 - 财政年份:2023
- 资助金额:
$ 44.24万 - 项目类别:
Neuronal IL-1R1 Signaling in Mild Closed Head Injury
轻度闭合性头部损伤中的神经元 IL-1R1 信号转导
- 批准号:
10656547 - 财政年份:2022
- 资助金额:
$ 44.24万 - 项目类别:
Translational Approaches to Mitigate Enhanced Alzheimer’s Disease Risk Following a Mild TBI
减轻轻度 TBI 后阿尔茨海默病风险增加的转化方法
- 批准号:
10090757 - 财政年份:2021
- 资助金额:
$ 44.24万 - 项目类别:
Administrative Supplement to Sleep Fragmentation and Alzheimer's Disease
睡眠碎片化和阿尔茨海默病的行政补充
- 批准号:
10555721 - 财政年份:2020
- 资助金额:
$ 44.24万 - 项目类别:
Cell-Specific Actions of IL-1 / IL-1R1 Signaling Following Traumatic Brain Injury
脑外伤后 IL-1/IL-1R1 信号传导的细胞特异性作用
- 批准号:
10307112 - 财政年份:2018
- 资助金额:
$ 44.24万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 44.24万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 44.24万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 44.24万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 44.24万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 44.24万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 44.24万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 44.24万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 44.24万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 44.24万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 44.24万 - 项目类别:
Research Grant














{{item.name}}会员




